Tahl Cindy

Avg. Two Year Performance

No purchase track record
(< 1%) Avg. Sale Return
0% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(4%)(2%)(2%)(6%)(< 1%)
Sale Success Rate2 of 130 of 130 of 130 of 130 of 13
Drugs » Biotechnology

General Counsel and Secretary:

Holdings: 342.36K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--